Abstract
To explore the risk factors (causes or possible causes) of systemic reactions induced by subcutaneous immunotherapy (SCIT) through clinical observations and develop countermeasures for preventing further SCIT-induced systemic reactions. Each patient on SCIT at our department from December 1993 to September 2013 was inquired about systemic reactions induced by SCIT. Individuals with systemic reactions immediately after SCIT were included. Clinical history and manifestations were inquired and recorded carefully. Risk factors of systemic reactions were probed and analyzed. SCIT schedule was adjusted according to the risk factors and the patients on continuous SCIT were followed up until the end of SCIT course. A total of 70 reactions were observed in 35 patients during the observation period. A large majority (97.1% (68/70) ) of systemic reactions occurred at a maximal concentration of 10(-2). Risk factor included an injection of maximal dosage (0.6-1.0 ml of 10(-2) vial, 27.2% (28/103) ), a further injection of large dosage (0.1-0.5 ml of 10(-2) vial) during pollen season (20.4% (21/103) ), incremental dose regardless of marked local reaction (12.6% (13/103) ), suspected incorrect injection procedure(12.6% (13/103) ) and an injection with a wrong vial of higher concentration (9.7% (10/103) ). Countermeasures were taken accordingly, include stopping injection of maximal dosage, avoiding SCIT of 10(-2) vial on pollen season, decreasing SCIT dosage on existence of large local reactions, performing SCIT only at medical institutions capable of managing anaphylaxis and implementing normalized injection procedures. Most patients (n = 29) finished the course of SCIT successfully without further systemic reactions. Six patients ceased SCIT for personal reasons or on medical advice. Probing the risk factors of systemic reactions induced by SCIT and adopting countermeasures accordingly prevent further systemic reactions. It may provide rationales for preventing or minimizing systemic reactions during SCIT.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
